Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
17.83
+0.25 (1.39%)
Jul 21, 2026, 9:43 AM EDT - Market open
Odyssey Therapeutics Revenue
Odyssey Therapeutics had revenue of $1.06M in the twelve months ending March 31, 2026. In the year 2025, Odyssey Therapeutics had annual revenue of $2.98M, down -33.45%.
Revenue (ttm)
$1.06M
Revenue Growth
-33.45%
P/S Ratio
795.55
Revenue / Employee
$10,580
Employees
100
Market Cap
853.43M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.98M | -1.50M | -33.45% |
| Dec 31, 2024 | 4.47M | 3.44M | 331.24% |
| Dec 31, 2023 | 1.04M | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionODTX News
- 4 weeks ago - Odyssey Therapeutics Slides: Corporate presentation - Filings
- 4 weeks ago - Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Odyssey Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Odyssey Therapeutics Earnings release: Q1 2026 - Filings
- 7 weeks ago - Wedbush bullish on Odyssey Therapeutics, initiates with an Outperform - TheFly
- 7 weeks ago - Wedbush bullish on Odyssey Therapeutics, initiates with an Outperform - TheFly
- 7 weeks ago - Odyssey Therapeutics initiated with an Outperform at Wedbush - TheFly
- 7 weeks ago - Odyssey Therapeutics initiated with an Outperform at Oppenheimer - TheFly